Text this: Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

 _    _      ___      _  _      ___      _____   
| |  | ||   / _ \\   | \| ||   / _ \\   /  ___|| 
| |/\| ||  / //\ \\  |  ' ||  | / \ || | // __   
|  /\  || |  ___  || | .  ||  | \_/ || | \\_\ || 
|_// \_|| |_||  |_|| |_|\_||   \___//   \____//  
`-`   `-` `-`   `-`  `-` -`    `---`     `---`